Foster City, CA, United States of America

Bainian Feng




Average Co-Inventor Count = 4.3

ph-index = 14

Forward Citations = 833(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2012 - 2013)
  • Foster City, CA (US) (2003 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: A Closer Look at Innovator Bainian Feng

Introduction: Bainian Feng, based in Foster City, California, is a prolific inventor with an impressive portfolio of 31 patents. His work focuses primarily on the development of novel therapeutic agents aimed at combating serious health conditions, including malignancies and cellular proliferative diseases.

Latest Patents: One of Bainian Feng's notable recent inventions includes compounds that serve as inhibitors of IAP, which are essential for treating malignancies. These compounds follow a specific general formula, demonstrating a sophisticated understanding of chemical interactions in therapeutic applications. Additionally, Feng has disclosed methods and compositions utilizing quinazolinones, which are particularly useful for addressing diseases associated with KSP kinesin activity.

Career Highlights: Feng has made significant contributions in the pharmaceutical industry through his work with well-known companies such as Cytokinetics, Inc. and Genentech, Inc. His expertise in the field has allowed him to explore innovative solutions that bridge the gap between research and application.

Collaborations: Throughout his career, Bainian Feng has collaborated with esteemed professionals, including Gustave Bergnes and Whitney Walter Smith. Together, they have advanced the research and development of groundbreaking therapies, enhancing the medical field's capacity to treat complex diseases.

Conclusion: Bainian Feng's contributions to innovation and invention highlight the crucial role of dedicated inventors in advancing healthcare solutions. With his extensive patent portfolio and collaborations, he continues to drive forward the research that promises better therapeutic interventions for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…